JP2023522701A5 - - Google Patents

Info

Publication number
JP2023522701A5
JP2023522701A5 JP2022563451A JP2022563451A JP2023522701A5 JP 2023522701 A5 JP2023522701 A5 JP 2023522701A5 JP 2022563451 A JP2022563451 A JP 2022563451A JP 2022563451 A JP2022563451 A JP 2022563451A JP 2023522701 A5 JP2023522701 A5 JP 2023522701A5
Authority
JP
Japan
Application number
JP2022563451A
Other languages
Japanese (ja)
Other versions
JP2023522701A (ja
JPWO2021216556A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/028166 external-priority patent/WO2021216556A2/en
Publication of JP2023522701A publication Critical patent/JP2023522701A/ja
Publication of JP2023522701A5 publication Critical patent/JP2023522701A5/ja
Publication of JPWO2021216556A5 publication Critical patent/JPWO2021216556A5/ja
Pending legal-status Critical Current

Links

JP2022563451A 2020-04-20 2021-04-20 Msh3調節のためのオリゴヌクレオチド Pending JP2023522701A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063012603P 2020-04-20 2020-04-20
US63/012,603 2020-04-20
PCT/US2021/028166 WO2021216556A2 (en) 2020-04-20 2021-04-20 Oligonucleotides for msh3 modulation

Publications (3)

Publication Number Publication Date
JP2023522701A JP2023522701A (ja) 2023-05-31
JP2023522701A5 true JP2023522701A5 (https=) 2024-05-02
JPWO2021216556A5 JPWO2021216556A5 (https=) 2024-05-02

Family

ID=78270051

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022563451A Pending JP2023522701A (ja) 2020-04-20 2021-04-20 Msh3調節のためのオリゴヌクレオチド

Country Status (6)

Country Link
US (1) US20210355491A1 (https=)
EP (1) EP4138860A4 (https=)
JP (1) JP2023522701A (https=)
AU (1) AU2021260581A1 (https=)
CA (1) CA3176204A1 (https=)
WO (1) WO2021216556A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3277811B1 (en) 2015-04-03 2020-12-23 University of Massachusetts Fully stabilized asymmetric sirna
US10633653B2 (en) 2015-08-14 2020-04-28 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
JP7406793B2 (ja) 2017-06-23 2023-12-28 ユニバーシティー オブ マサチューセッツ 2テイル自己デリバリー型siRNAおよび関連方法
JP7627042B2 (ja) 2018-08-23 2025-02-05 ユニバーシティー オブ マサチューセッツ O-メチルリッチ完全安定化オリゴヌクレオチド
CN113614232A (zh) 2019-01-18 2021-11-05 马萨诸塞大学 动态药代动力学修饰锚
MX2022001710A (es) 2019-08-09 2022-05-10 Univ Massachusetts Oligonucleótidos modificados químicamente dirigidos a los snp.
US12365894B2 (en) 2019-09-16 2025-07-22 University Of Massachusetts Branched lipid conjugates of siRNA for specific tissue delivery
WO2021226549A1 (en) * 2020-05-08 2021-11-11 Triplet Therapeutics, Inc. Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity
WO2021242883A1 (en) 2020-05-26 2021-12-02 University Of Massachusetts Synthetic oligonucleotides having regions of block and cluster modifications
AR122534A1 (es) 2020-06-03 2022-09-21 Triplet Therapeutics Inc Métodos para el tratamiento de los trastornos de expansión por repetición de nucleótidos asociados con la actividad de msh3
EP4164656A4 (en) * 2020-06-11 2025-10-22 Ionis Pharmaceuticals Inc COMPOUNDS AND METHODS FOR REDUCING MSH3 EXPRESSION
WO2022212231A2 (en) 2021-03-29 2022-10-06 Alnylam Pharmaceuticals, Inc. Huntingtin (htt) irna agent compositions and methods of use thereof
WO2023076450A2 (en) * 2021-10-29 2023-05-04 Alnylam Pharmaceuticals, Inc. HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
US20230313198A1 (en) * 2021-12-17 2023-10-05 University Of Massachusetts Oligonucleotides for mlh3 modulation
US20240035027A1 (en) * 2022-05-04 2024-02-01 University Of Massachusetts Oligonucleotides for pms2 modulation
AU2023272008A1 (en) * 2022-05-16 2024-12-12 Atalanta Therapeutics, Inc. Compositions and methods for treatment of microsatellite dna expansion disorders
WO2024064954A2 (en) * 2022-09-23 2024-03-28 The Children's Hospital Of Philadelphia Compositions and methods for treating huntington's disease and related disorders
WO2025078602A1 (en) * 2023-10-11 2025-04-17 Uniqure Biopharma B.V. Nucleic acid regulation of msh3 in repeat expansion disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO974597A0 (en) * 1997-10-10 1997-11-06 Rhone-Poulenc Agro Methods for obtaining plant varieties
US7361468B2 (en) * 2004-07-02 2008-04-22 Affymetrix, Inc. Methods for genotyping polymorphisms in humans
WO2013120037A1 (en) * 2012-02-10 2013-08-15 Regents Of The University Of Minnesota Dna assimilation
WO2015171918A2 (en) * 2014-05-07 2015-11-12 Louisiana State University And Agricultural And Mechanical College Compositions and uses for treatment thereof
TN2017000354A1 (en) * 2015-02-10 2019-01-16 Genzyme Corp VARIANT RNAi
SMT202000454T1 (it) * 2015-04-03 2020-11-10 Univ Massachusetts Cmposti oligonucleotidici per bersagliare l'mrn della huntingtina
US20170009304A1 (en) * 2015-07-07 2017-01-12 Splicingcodes.Com Method and kit for detecting fusion transcripts
WO2017132669A1 (en) * 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
JP7714162B6 (ja) * 2018-12-03 2025-09-08 タケダ ファーマシューティカルズ ユーエスエー インコーポレイテッド Msh3活性に関連するトリヌクレオチドリピート伸長障害の処置のための方法

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
JP2023528755A5 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)